Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 29/06/20041 min de lecture
Prescription Drug Products; Digoxin Elixir; Extension to Obtain Marketing Approval
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing that it will continue to exercise enforcement discretion to assure the continued availability of digoxin elixirs after June 28, 2004, allowing manufacturers to continue to market these products without approved applications until December 28, 2004. FDA is granting this extension to give manufacturers of digoxin elixir additional time to obtain marketing approval and bring products to market.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →